Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Factor II”

827 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 827 results

Not applicableLooking for participantsNCT07275476
What this trial is testing

Pregnancy and Fibrin Clot Properties

Who this might be right for
Fibrin Blood ClotPregnancyPregnancy Complicated by Cardiovascular Disorders as Postpartum Condition, Delivered During Previous Episode
Jagiellonian University 100
Large-scale testing (Phase 3)Ended earlyNCT00527943
What this trial is testing

Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Particpants With Acute Coronary Syndrome (TRA•CER) (Study P04736)

Who this might be right for
AtherosclerosisMyocardial IschemiaMyocardial Infarction
Merck Sharp & Dohme LLC 12,944
Testing effectiveness (Phase 2)UnknownNCT04318223
What this trial is testing

Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal Therapy

Who this might be right for
Metastatic Breast CancerLocally Advanced Breast Cancer
Consorzio Oncotech 168
Testing effectiveness (Phase 2)UnknownNCT04034589
What this trial is testing

Pyrotinib in Combination With Fulvestrant in Patients With HER2 Positive，HR-Positive Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 46
Testing effectiveness (Phase 2)Ended earlyNCT03686345
What this trial is testing

Midostaurin Associated With Standard Chemotherapy in Patients With Core-binding Factor Leukemia

Who this might be right for
Core Binding Factor Acute Myeloid Leukemia (CBF-AML)
Niguarda Hospital 34
Testing effectiveness (Phase 2)Study completedNCT00506857
What this trial is testing

Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support

Who this might be right for
Hematologic Malignancies
M.D. Anderson Cancer Center 82
Not applicableStudy completedNCT01744431
What this trial is testing

Can Thrombin Generation Measurement Predict the Risk of Venous Thromboembolism in Acute Ill Patients

Who this might be right for
Venous Thromboembolism
HaEmek Medical Center, Israel 400
Not applicableWithdrawnNCT02429453
What this trial is testing

FFP Versus PCC in Intracranial Hemorrhage

Who this might be right for
Intracranial Hemorrhage, TraumaticIntracranial Hemorrhage, Spontaneous
University of Utah
Testing effectiveness (Phase 2)Study completedNCT00827372
What this trial is testing

Vascular Endothelial Growth Factor (VEGF) Inhibition in Patients With Unilateral Upper Extremity Lymphedema Following Treatment for Cancer

Who this might be right for
Lymphedema
Kathy Miller 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT02502786
What this trial is testing

Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma

Who this might be right for
Recurrent Osteosarcoma
Memorial Sloan Kettering Cancer Center 46
Testing effectiveness (Phase 2)UnknownNCT02285530
What this trial is testing

GDF15 Based TPF Induction Chemotherapy for OSCC Patients

Who this might be right for
Mouth NeoplasmsCarcinoma, Squamous Cell
Shanghai Jiao Tong University School of Medicine 72
Not applicableStudy completedNCT03795883
What this trial is testing

The Thrombotic Potential of Heart Chambers in the Presence or Absence of Atrial Fibrillation.

Who this might be right for
Atrial FibrillationThrombosis CardiacLeft Atrial Thrombosis
Rambam Health Care Campus 47
Not applicableStudy completedNCT05484830
What this trial is testing

Coagulation in Acute Aortic Dissection

Who this might be right for
Acute Aortic DissectionCoagulation Disorder
Ivy susanne Modrau, MD 26
Testing effectiveness (Phase 2)Study completedNCT01325428
What this trial is testing

Afatinib (BIBW2992) in HER2 (Human Epidermal Growth Factor Receptor 2)-Overexpressing Inflammatory Breast Cancer

Who this might be right for
Breast Neoplasms
Boehringer Ingelheim 26
Testing effectiveness (Phase 2)Study completedNCT05205863
What this trial is testing

Dose-Response in PD and Safety of Cofact Under VKA Anticoagulation

Who this might be right for
Healthy Volunteers
Prothya Biosolutions 69
Testing effectiveness (Phase 2)Ended earlyNCT05636267
What this trial is testing

Study of AK119 and AK112 With or Without Chemotherapy for NSCLC Patients

Who this might be right for
NSCLC
Akeso 59
Testing effectiveness (Phase 2)Study completedNCT00554463
What this trial is testing

G-CSF and Pegfilgrastim in Treating Neutropenia in Patients Undergoing Radiation Therapy and Chemotherapy for Limited Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 5
Not applicableEnded earlyNCT00814333
What this trial is testing

Trial Comparing Outcomes With Merocel Packing or Thrombin-JMI for Anterior Epistaxis

Who this might be right for
Epistaxis
University of Kansas Medical Center 1
Testing effectiveness (Phase 2)Ended earlyNCT00447265
What this trial is testing

Etanercept for the Treatment of Lupus Nephritis

Who this might be right for
Lupus Nephritis
National Institute of Allergy and Infectious Diseases (NIAID) 1
Testing effectiveness (Phase 2)Ended earlyNCT04637698
What this trial is testing

OH2 Oncolytic Viral Therapy in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Binhui Biopharmaceutical Co., Ltd. 5
Load More Results